Stoppa-Lyonnet D - Search Results

1

Functional classification of ATM variants in ataxia-telangiectasia patients.

Fiévet A, Bellanger D, Rieunier G, Dubois d'Enghien C, Sophie J, Calvas P, Carriere JP, Anheim M, Castrioto A, Flabeau O, Degos B, Ewenczyk C, Mahlaoui N, Touzot F, Suarez F, Hully M, Roubertie A, Aladjidi N, Tison F, Antoine-Poirel H, Dahan K, Doummar D, Nougues MC, Ioos C, Rougeot C, Masurel A, Bourjault C, Ginglinger E, Prieur F, Siri A, Bordigoni P, Nguyen K, Philippe N, Bellesme C, Demeocq F, Altuzarra C, Mathieu-Dramard M, Couderc F, Dörk T, Auger N, Parfait B, Abidallah K, Moncoutier V, Collet A, Stoppa-Lyonnet D, Stern MH. Fiévet A, et al. Hum Mutat. 2019 Oct;40(10):1713-1730. doi: 10.1002/humu.23778. Epub 2019 May 17. Hum Mutat. 2019. PMID: 31050087

2

[Ataxia telangiectasia: what impact in clinical oncology?].

Stoppa-Lyonnet D, Aurias A. Stoppa-Lyonnet D, et al. Bull Cancer. 1992;79(7):645-50. Bull Cancer. 1992. PMID: 1467590 Review. French.

3

Deregulated apoptosis in ataxia telangiectasia: association with clinical stigmata and radiosensitivity.

Duchaud E, Ridet A, Stoppa-Lyonnet D, Janin N, Moustacchi E, Rosselli F. Duchaud E, et al. Cancer Res. 1996 Mar 15;56(6):1400-4. Cancer Res. 1996. PMID: 8640831

4

Inactivation of the ATM gene in T-cell prolymphocytic leukemias.

Stoppa-Lyonnet D, Soulier J, Laugé A, Dastot H, Garand R, Sigaux F, Stern MH. Stoppa-Lyonnet D, et al. Blood. 1998 May 15;91(10):3920-6. Blood. 1998. PMID: 9573030 Free article.

5

Breast cancer risk in ataxia telangiectasia (AT) heterozygotes: haplotype study in French AT families.

Janin N, Andrieu N, Ossian K, Laugé A, Croquette MF, Griscelli C, Debré M, Bressac-de-Paillerets B, Aurias A, Stoppa-Lyonnet D. Janin N, et al. Br J Cancer. 1999 Jun;80(7):1042-5. doi: 10.1038/sj.bjc.6690460. Br J Cancer. 1999. PMID: 10362113 Free PMC article.

6

No germline ATM mutation in a series of 16T-cell prolymphocytic leukemias.

Stoppa-Lyonnet D, Laugé A, Sigaux F, Stern MH. Stoppa-Lyonnet D, et al. Blood. 2000 Jul 1;96(1):374-6. Blood. 2000. PMID: 10939806 No abstract available.

7

Cancer risk in heterozygotes for ataxia-telangiectasia.

Geoffroy-Perez B, Janin N, Ossian K, Laugé A, Croquette MF, Griscelli C, Debré M, Bressac-de-Paillerets B, Aurias A, Stoppa-Lyonnet D, Andrieu N. Geoffroy-Perez B, et al. Int J Cancer. 2001 Jul 15;93(2):288-93. doi: 10.1002/ijc.1329. Int J Cancer. 2001. PMID: 11410879

8

Phenotypic cellular characterization of an ataxia telangiectasia patient carrying a causal homozygous missense mutation.

Angèle S, Laugé A, Fernet M, Moullan N, Beauvais P, Couturier J, Stoppa-Lyonnet D, Hall J. Angèle S, et al. Hum Mutat. 2003 Feb;21(2):169-70. doi: 10.1002/humu.9107. Hum Mutat. 2003. PMID: 12552566

9

Haplotype analysis of the BRCA2 9254delATCAT recurrent mutation in breast/ovarian cancer families from Spain.

Campos B, Díez O, Odefrey F, Domènech M, Moncoutier V, Martínez-Ferrandis JI, Osorio A, Balmaña J, Barroso A, Armengod ME, Benítez J, Alonso C, Stoppa-Lyonnet D, Goldgar D, Baiget M. Campos B, et al. Hum Mutat. 2003 Apr;21(4):452. doi: 10.1002/humu.9133. Hum Mutat. 2003. PMID: 12655574

10

Characterisation of a 161 kb deletion extending from the NBR1 to the BRCA1 genes in a French breast-ovarian cancer family.

Gad S, Bièche I, Barrois M, Casilli F, Pages-Berhouet S, Dehainault C, Gauthier-Villars M, Bensimon A, Aurias A, Lidereau R, Bressac-de Paillerets B, Tosi M, Mazoyer S, Stoppa-Lyonnet D. Gad S, et al. Hum Mutat. 2003 Jun;21(6):654. doi: 10.1002/humu.9148. Hum Mutat. 2003. PMID: 14961556

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

492 results

Search Page

Filters